Venue
The Nontuberculous Mycobacteria (NTM) Australia Research Network is brought to you by leading clinicians, researchers and scientists.
Over the course of this event, attendees will have the opportunity to review clinical aspects of NTM diagnosis and management, hear about the latest research being conducted, and to discuss research priorities and opportunities for collaboration.
The objectives of the forum are to:
- Advance and disseminate clinical knowledge in the field of NTM
- Disseminate the latest advances in translational research from around the world.
- Provide a forum for researchers to present and discuss their work
- Facilitate collaborations across Australia to enhance the quality and outcomes of research in this field.
Program information
Please bookmark this webpage to check for the latest updates to the program. The full program, including invited speaker topics, selected abstracts and speaker bios will be available at a later date.
Overview
Thursday: Core Curriculum
This program is aimed at clinical and allied health professionals, with topics such as epidemiology, diagnostics, host susceptibility, radiology/laboratory developments, disease management, drug toxicity and the evidence behind the guidelines, plus case discussions and approaches for extrapulmonary or less common NTM infections.
Friday: Research Focus
This program will showcase the latest research developments relevant to NTM, including research studies and clinical trials in epidemiology, microbiology, diagnostics, host-pathogen interactions and novel therapies.
Friday: Patient Day Satellite Meeting
Due to a low number of registrations for this event, the Patient Day Satelite meeting will not be going ahead. Interested patients should keep an eye out for future online and in-person events that will include the topics listed in the Patient Day program. Email ntm@uq.edu.au to be added to the NTM group mailing list.
Registration
Registration for the NTM Symposium 2024 is now open. Early bird registration ends on 31 August 2024.
If you are registering for only 1 day, please indicate which day you will attend on the registration form (either Thursday 31 October or Friday 1 November 2024).
Pricing (AU$)
Early Bird (before 31/08/24) | Late (after 31/08/24) | |||
1 Day | 2 Days | 1 Day | 2 Days | |
Attendee | $80 | $150 | $100 | $200 |
Student | $50 | $100 | $50 | $100 |
Abstracts
Abstract submission is open.
Abstract submission closes at 17:00 AEST on Friday 30 August, 2024.
Please submit your abstracts by emailing to ntm@uq.edu.au in the following format:
- 1x A4 page, 12pt Times New Roman font
- Sections:
- State preference for Poster, Oral, or Either
- Title
- Authors (Last Name, Initial(s) and underline the presenting author
- Affiliations (use a superscript numbering system to reference authors)
- For the body of the abstract, use such headers as Background, Aims, Methods, Discussion and Conclusion where relevant
- Figures and tables are welcome but must fit on the same A4 page
Speakers
Kevin L. Winthrop, M.D., M.P.H.
Oregon Health & Science University, Portland, OR, USA
Kevin L. Winthrop, Professor of Public Health, Infectious Diseases, and Ophthalmology at Oregon Health and Science University, is a former staff infectious disease epidemiologist from the U.S. Centers for Disease Control and Prevention’s Division of Tuberculosis Elimination. He has co-authored over 400 publications, many detailing the epidemiologic and clinical aspects of nontuberculous mycobacterial diseases (NTM), tuberculosis, and other infections associated with rheumatic diseases and biologic immunosuppressive therapies. Clinically, he provides regional consultations for mycobacterial diseases and other chronic chest infections and serves as the medical consultant to the Oregon Public Health Division’s TB control program. His Center for Infectious Disease Studies has served as the lead institution and coordinating center for multiple cohort studies and clinical trials. He has served as a primary or senior investigator in many of these clinical and epidemiologic studies, and frequently collaborates with the Pulmonary Department on studies related to bronchiectasis. He founded the NTM Research Consortium and associated Clinical Trials Network which facilitate collaborative, multi-site grants and clinical trials among patients with NTM. He is a member of the graduate faculty at OHSU where he mentors public health students, medical students, and physicians in post-graduate training.
Jae-Joon Yim, M.D.
Gold sponsor
Silver sponsor
Supporter
